{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T19:52:31Z","timestamp":1793994751896,"version":"4.8.0"},"reference-count":10,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Cardiol"],"published-print":{"date-parts":[[2026,3,1]]},"abstract":"\n Importance<\/jats:title>\n Home blood pressure monitoring (HBPM) is essential and universally recommended for hypertension management, but patterns of real-world patient engagement with HBPM have not been studied and remain largely unknown.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To evaluate patient engagement with HBPM in a remote hypertension management program.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This retrospective cohort study analyzing prospectively collected program data was conducted within a remote hypertension management program at a large academic health care system, Mass General Brigham, in Boston, Massachusetts. Data were collected from from September 2018 to June 2022. Adults with uncontrolled hypertension enrolled in the program were eligible for inclusion. Data analyses were conducted from February to April 2025.<\/jats:p>\n <\/jats:sec>\n \n Interventions<\/jats:title>\n Patients received free automated HBPM devices, education, and ongoing personalized support from health care navigators via telephone and messaging, with algorithm-guided medication titration.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The primary outcome was engagement at baseline. Weekly HBPM frequency was categorized as no engagement (0 measurements), low engagement (1-11 measurements\/week), intermediate engagement (12-23 measurements\/week), and high engagement (24-28 measurements\/week).<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n A total of 3390 patients were enrolled in the remote hypertension program; median (IQR) patient age was 61 (52-69) years, with 1958 (57.8%) female patients. Mean (SD) systolic BP at baseline was 143 (13) mm Hg, and most patients had comorbidities, including 1369 patients (40.4%) with atherosclerotic cardiovascular disease and 996 (29.4%) with diabetes. At baseline, 1107 patients (32.7%) had no engagement, 484 (14.3%) had low engagement, 618 (18.2%) had intermediate engagement, and 1181 (34.8%) had high engagement.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this cohort study of a remote hypertension management program, patient engagement with HBPM was suboptimal despite free devices, education, and personalized support with a navigator. To support optimal HBPM, innovative methods of BP monitoring that are more convenient and less burdensome for patients may enhance engagement and improve hypertension management outcomes.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamacardio.2025.5196","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T16:00:39Z","timestamp":1769011239000},"page":"288","source":"Crossref","is-referenced-by-count":12,"title":["Patient Engagement With Home Blood Pressure Monitoring"],"prefix":"10.1001","volume":"11","author":[{"given":"Ozan","family":"Unlu","sequence":"first","affiliation":[{"name":"Accelerator for Clinical Transformation, Brigham and Women\u2019s Hospital, Boston, Massachusetts"},{"name":"Division of Cardiovascular Medicine, Brigham and Women\u2019s Hospital, Boston, Massachusetts"},{"name":"Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Zelle","sequence":"additional","affiliation":[{"name":"Accelerator for Clinical Transformation, Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"Cannon","sequence":"additional","affiliation":[{"name":"Accelerator for Clinical Transformation, Brigham and Women\u2019s Hospital, Boston, Massachusetts"},{"name":"Division of Cardiovascular Medicine, Brigham and Women\u2019s Hospital, Boston, Massachusetts"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simin","family":"Lee","sequence":"additional","affiliation":[{"name":"Accelerator for Clinical Transformation, Brigham and Women\u2019s Hospital, Boston, Massachusetts"},{"name":"Division of Cardiovascular Medicine, Brigham and Women\u2019s Hospital, Boston, Massachusetts"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian","family":"McPartlin","sequence":"additional","affiliation":[{"name":"Accelerator for Clinical Transformation, Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Subramaniam","sequence":"additional","affiliation":[{"name":"Accelerator for Clinical Transformation, Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Tucci","sequence":"additional","affiliation":[{"name":"Accelerator for Clinical Transformation, Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Oates","sequence":"additional","affiliation":[{"name":"Accelerator for Clinical Transformation, Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Figueroa","sequence":"additional","affiliation":[{"name":"Accelerator for Clinical Transformation, Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hunter","family":"Nichols","sequence":"additional","affiliation":[{"name":"Accelerator for Clinical Transformation, Brigham and Women\u2019s Hospital, Boston, Massachusetts"},{"name":"Division of Pharmacy, Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tabitha V.","family":"Rutkowski","sequence":"additional","affiliation":[{"name":"Accelerator for Clinical Transformation, Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander J.","family":"Blood","sequence":"additional","affiliation":[{"name":"Accelerator for Clinical Transformation, Brigham and Women\u2019s Hospital, Boston, Massachusetts"},{"name":"Division of Cardiovascular Medicine, Brigham and Women\u2019s Hospital, Boston, Massachusetts"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin M.","family":"Scirica","sequence":"additional","affiliation":[{"name":"Accelerator for Clinical Transformation, Brigham and Women\u2019s Hospital, Boston, Massachusetts"},{"name":"Division of Cardiovascular Medicine, Brigham and Women\u2019s Hospital, Boston, Massachusetts"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi D. L.","family":"Fisher","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts"},{"name":"Division of Endocrinology, Diabetes and Hypertension, Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"2","key":"hbr250023r1","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1161\/HYPERTENSIONAHA.114.03292","article-title":"Office, home, and ambulatory blood pressures as predictors of cardiovascular risk.","volume":"64","author":"Niiranen","year":"2014","journal-title":"Hypertension"},{"issue":"1","key":"hbr250023r2","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1161\/01.HYP.0000170138.56903.7a","article-title":"Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study.","volume":"46","author":"Dolan","year":"2005","journal-title":"Hypertension"},{"issue":"38","key":"hbr250023r3","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","article-title":"2024 ESC guidelines for the management of elevated blood pressure and hypertension.","volume":"45","author":"McEvoy","year":"2024","journal-title":"Eur Heart J"},{"issue":"10","key":"hbr250023r4","doi-asserted-by":"publisher","first-page":"e212","DOI":"10.1161\/HYP.0000000000000249","article-title":"2025 AHA\/ACC\/AANP\/AAPA\/ABC\/ACCP\/ACPM\/AGS\/AMA\/ASPC\/NMA\/PCNA\/SGIM Guideline for the prevention, detection, evaluation and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines.","volume":"82","author":"Jones","year":"2025","journal-title":"Hypertension"},{"issue":"1","key":"hbr250023r5","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1001\/jamacardio.2022.4018","article-title":"Results of a remotely delivered hypertension and lipid program in more than 10?000 patients across a diverse health care network.","volume":"8","author":"Blood","year":"2023","journal-title":"JAMA Cardiol"},{"issue":"5","key":"hbr250023r6","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1055\/s-0041-1739195","article-title":"Workflow automation for a virtual hypertension management program.","volume":"12","author":"Gordon","year":"2021","journal-title":"Appl Clin Inform"},{"issue":"1","key":"hbr250023r7","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2337\/dc23-1520","article-title":"Efficacy and safety of continuous glucose monitoring and intermittently scanned continuous glucose monitoring in patients with type 2 diabetes: a systematic review and meta-analysis of interventional evidence.","volume":"47","author":"Seidu","year":"2024","journal-title":"Diabetes Care"},{"issue":"5","key":"hbr250023r8","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1093\/ajh\/hpaf003","article-title":"Continual versus occasional blood pressure (COOL-BP) in remote hypertension management.","volume":"38","author":"Unlu","year":"2025","journal-title":"Am J Hypertens"},{"key":"hbr250023r9","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1396962","article-title":"Optimizing time-in-target-range assessment for blood pressure: insights from a large-scale study with continual cuffless monitoring.","volume":"11","author":"Fisher","year":"2024","journal-title":"Front Med (Lausanne)"},{"issue":"6","key":"hbr250023r10","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1001\/jamacardio.2025.0662","article-title":"Cuffless blood pressure measurement devices-international perspectives on accuracy and clinical use: a narrative review.","volume":"10","author":"Yang","year":"2025","journal-title":"JAMA Cardiol"}],"container-title":["JAMA Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/articlepdf\/2843920\/jamacardiology_unlu_2026_br_250023_1773061346.05415.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T15:00:55Z","timestamp":1773241255000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/fullarticle\/2843920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,1]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamacardio.2025.5196","relation":{},"ISSN":["2380-6583"],"issn-type":[{"value":"2380-6583","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,1]]}}}